Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Iranian naval commander Alireza Tangsiri killed in attack, says Israel - 2Top Smoothie Flavor: What's Your Mix?
- 3Rights group: At least 2,500 deaths during protest crackdown in Iran
- 4The most effective method to Look at Medical caretaker Compensations Across Various Clinics
- 5At least 36 dead in major fire in Hong Kong residential blocks
- They relied on marijuana to get through the day. But then days felt impossible without it
- Kremlin: Russian troops conquer Pokrovsk after year of intense combat
- The next frontier in space is closer than you think – welcome to the world of very low Earth orbit satellites
- UN experts urge investigation into Israel’s killing of Lebanese journalists
- 'Malcolm in the Middle' reboot releases 1st trailer, reuniting Frankie Muniz and Bryan Cranston: Watch here
- Which Startup's Innovation Could Reform Medical care?
- The Best Portable Applications for Emotional wellness and Prosperity
- Cocoa Prices Undercut Amid the Prospects of Abundant Supplies
- Former Israeli judge does not expect Netanyahu to be pardoned
